Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the recipient of a significant decrease in short interest in July. As of July 15th, there was short interest totalling 700 shares, a decrease of 46.2% from the June 30th total of 1,300 shares. Based on an average daily volume of 1,300 shares, the days-to-cover ratio is currently 0.5 days.

Revolution Medicines Price Performance

Shares of NASDAQ:RVMDW remained flat at $0.21 during midday trading on Friday. The stock had a trading volume of 100 shares, compared to its average volume of 5,970. Revolution Medicines has a 1 year low of $0.03 and a 1 year high of $1.05. The stock’s 50 day moving average price is $0.15 and its 200 day moving average price is $0.19.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.